Isoxazole derivatives for the treatment of irritable bowel syndrome
US5434174A · kind A · utility
31Cited by
2References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 1993 |
| Grant date | Jul 18, 1995 |
| Priority date | — |
| Expiry date | Apr 20, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations adapted for the treatment of IBS comprising those derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.